Global Cardiovascular Ultrasound System Market Size & Trends Report Segmented by Test Type (Transthoracic, Transesophageal, Stress Echocardiogram), Technology (2D, 3D/4D, Doppler), Display (Color, Black/White), End-user (Hospitals, ASCs) & Regional Forecast to 2031

Cardiovascular ultrasound systems are non-invasive diagnostic imaging platforms used to visualize the structure and function of the heart and vascular system through high-frequency sound waves. They are essential for evaluating cardiac structure, including chamber size and valve integrity, as well as functional data like myocardial wall motion. Additionally, these systems are used to detect cardiac pathologies, including cardiomyopathy, structural abnormalities, and heart valve diseases. Further, they allow clinicians to assess vascular integrity, monitor blood flow patterns, and quickly diagnose conditions like pericardial effusion or blood clots in an emergency. The market includes cart-based and portable ultrasound systems, including handheld, AI-enabled devices, along with associated software and transducers designed for applications such as transthoracic echocardiography, transesophageal echocardiography, and stress echocardiography, among others.

Rising prevalence of cardiovascular disorders to drive demand for ultrasound procedures

The increasing global prevalence of cardiovascular diseases is a fundamental driver for cardiovascular ultrasound system adoption. Conditions such as coronary artery disease, heart failure, and valvular disorders require frequent non-invasive imaging for diagnosis, risk stratification, and longitudinal monitoring. According to the World Health Organization (WHO), CVDs were responsible for 19.8 million deaths in 2022, which was almost 32% of all global fatalities. Approximately one-third of these deaths occurred prematurely, in individuals under the age of 70, highlighting the expanding burden of CVDs across both younger and older populations. In the US alone, more than 915k people died of heart disease in 2023, accounting for one in every three deaths.

Cardiovascular ultrasound, including echocardiography (ECG) and vascular ultrasound, serves as a safe and cost-effective diagnostic tool for cardiovascular diseases (CVDs). With the surge in the number of CVDs due to factors like aging populations and lifestyle choices, ultrasound is crucial for diagnosing and monitoring these conditions, with advancements moving toward 3D/4D imaging and AI. As lifestyle-related risk factors such as obesity, diabetes, hypertension, and sedentary behaviour become more widespread, the clinical reliance on echocardiography continues to expand.

To learn more about this report, download the PDF brochure

Shift toward point-of-care and decentralized cardiac diagnostics to drive market growth

Traditional cardiac diagnostic tools, such as cardiac catheterization (angiography), require inserting tubes into blood vessels, posing risks of infection, bleeding, or vascular injury. However, cardiovascular ultrasound eliminates these risks, which has led to the increasing adoption of non-invasive diagnostic approaches that reduce procedural risks, hospital stay, and overall healthcare costs.

Furthermore, cardiovascular ultrasound uses no ionizing radiation, making it safe to perform repeatedly on vulnerable patients, such as those with kidney disease who cannot tolerate iodinated contrast media. The growing demand for point-of-care diagnostics has accelerated the development and adoption of handheld and portable ultrasound devices, allowing clinicians to perform real-time imaging in emergency departments, intensive care units (ICUs), non-acute wards, ambulatory clinics, and even during home health visits.

These systems support immediate clinical decision-making by eliminating the logistical constraints associated with fixed imaging equipment, as they bring the diagnostic technology to the patient rather than transporting a critical patient to a specialized imaging suite. As healthcare delivery continues to move toward patient-centric models, the preference for compact, easy-to-use imaging tools is becoming more pronounced, reinforcing demand for point-of-care cardiovascular ultrasound platforms across both acute and outpatient settings.

Additionally, handheld devices can stream live video over 5G/Wi-Fi to specialists located elsewhere, leading to the emergence of tele-ultrasound and remote consultation capabilities that extend the clinical utility of handheld ultrasound devices beyond physical care settings. The integration of cardiovascular ultrasound systems with telemedicine platforms enables real-time image sharing and specialist input in rural, underserved, or resource-limited settings. Lastly, with advancements in network connectivity and digital infrastructure, tele-ultrasound is expected to play a growing role in collaborative and distributed cardiac care models

Integration of artificial intelligence in image interpretation, a significant growth opportunity

The integration of artificial intelligence (AI) and advanced analytics into cardiovascular ultrasound is a significant trend reshaping cardiac imaging.  AI-based software tools, leveraging deep learning and convolutional neural networks (CNNs), are being incorporated into imaging workflows automatically identify standard echocardiographic views and perform crucial measurements in seconds rather than minutes.

AI-driven systems remove the subjectivity of manual, operator-dependent tracing, significantly reducing the time spent on routine tasks. AI assists in detecting wall motion abnormalities or pathologies that may be overlooked by the human eye, facilitating early diagnosis of any cardiac abnormalities or heart failure. Ultimately, AI-driven tools ensure standardized, comprehensive reporting and consistent, protocol-adherent documentation, minimizing the risk of missing critical diagnostic data. 

To learn more about this report, download the PDF brochure

Test Type Segment Outlook

Cardiovascular ultrasound system market segmentation by test type is categorized into transthoracic echocardiography (TTE), transesophageal echocardiography (TEE), stress echocardiography, and fetal echocardiography, among others. The TTE holds the largest share of the market, primarily driven by its non-invasive nature, cost-effectiveness, and advancements in portable, bedside imaging. Followed by TTE, stress echocardiography is the fastest-growing segment due to increasing awareness of preventive cardiology and the rising prevalence of ischemic heart diseases. Further, the fetal echocardiography segment is experiencing rapid growth, driven by increasing awareness of prenatal cardiac screening and the need for early detection of congenital heart defects.

Regional Outlook: North America is expected to hold a major share of the cardiovascular ultrasound system market

From a geographical perspective, North America holds the largest share in the cardiovascular ultrasound system market, driven by the rising burden of cardiovascular diseases, advanced healthcare infrastructure, and rapid adoption of advanced diagnostic technologies. Further, the surge in the number of people having CVDs in the US makes it the primary contributor due to the widespread use of echocardiography in both inpatient and outpatient care.

Europe represents the second-largest market, supported by established healthcare systems, high demand for advanced, radiation-free imaging technologies and favourable reimbursement policies. However, Asia-Pacific is expected to witness the fastest growth, primarily due to the rising number of cardiovascular diseases, driven by sedentary lifestyles and urbanization, which is accelerating demand for early diagnosis and monitoring. Moreover, with improving healthcare infrastructure and expanding access to diagnostic services in emerging countries are driving the market growth in the region.

Competitive Landscape Analysis

The global cardiovascular ultrasound system market is marked by the presence of established and emerging market players such as Koninklijke Philips N.V. (Netherlands); GE Healthcare (US); Siemens Healthineers AG (Germany); Canon Medical Systems (Japan); Mindray Medical International Limited (China); Samsung Medison Co., Ltd. (South Korea); FUJIFILM SonoSite, Inc. (Japan); Konica Minolta Inc. (Japan); and Esaote SpA (Italy); among others. Some of the key strategies adopted by market players include product innovation and development, strategic partnerships and collaborations, mergers and acquisitions, and geographic expansion.

Get a sample report for competitive landscape analysis

Report Scope

Global Cardiovascular Ultrasound System Market Segmentation

This report by Medi-Tech Insights provides the size of the global cardiovascular ultrasound system market at the regional- and country-level from 2024 to 2031. The report further segments the market based on test type, technology, display, and end-user.

Market Size & Forecast (2024-2031), By Test Type, USD Billion

• Transthoracic Echocardiography
• Transesophageal Echocardiography
• Stress Echocardiography
• Fetal Echocardiography
• Others

Market Size & Forecast (2024-2031), By Technology, USD Billion

• 2D
• 3D/4D
• Doppler

Market Size & Forecast (2024-2031), By Display, USD Billion

• Color
• Black & White (B/W) Display

Market Size & Forecast (2024-2031), By End-user, USD Billion

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers
• Others

Market Size & Forecast (2024-2031), By Region, USD Billion

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Related Reports

Global Handheld Ultrasound Devices Market Size & Trends Report Segmented by Technology (2D, 3D/4D, Doppler), Application (OBGY, Cardiology, Vascular, Abdominal Imaging, MSK, Urology), End User (Hospitals, Diagnostic Imaging Centers, ASCs) & Regional Forecast to 2030

Global Point-Of-Care Ultrasound Devices Market Size & Trends Report Segmented by Type (Diagnostics, Therapeutics), Portability (Trolley/Cart-Based, Compact/Handheld), Application (Emergency Medicine, Cardiology, Musculoskeletal), End User & Regional Forecast to 2030

Global Intracardiac Echocardiography (ICE) Market Size Report Segmented by Product Type (Ultrasound, Catheter, Console, Software), Application (Electrophysiology, Structural Heart Defects, Cardiac Monitoring), End-user & Forecast to 2030